Evaluation of estrogen receptor expression and its relationship with clinicopathologic findings in gastric cancer

Authors
Hamid Saeidi 1
Mohammad Reza Ghavam Nasiri 2
Soodabeh Shahidsales 2
Ali Taghizadeh Kermani 2
Simin Hematti 3
Seyedeh Setareh Roodbari 1
Mohammad Hossein Mottaghi Shahri 4
Sepideh Chagharvand 1
1 Cancer Research Center, Guilan University of Medical Science (GUMS), Guilan, Iran
2 Cancer Research Center, Faculty of Medicine, Isfahan University of Medical Sciences (IUMS), Isfahan, Iran
3 Department of Radiotherapy and Oncology, School of Medicine, Isfahan University of Medical Sciences (IUMS), Isfahan, Iran
4 General Physicians, Cancer Research Center, Mashhad University of Medical Sciences (MUMS), Mashhad, Iran
Abstract
Background: The presence of estrogen receptor alpha has been reported in the cell and tissue levels in gastric cancer; however, its impact on patients' survival remains unclear. The aim of this study was to investigate the expression of estrogen receptor in gastric carcinoma as well as its relationship with the clinicopathologic findings of the patients.
Materials and Methods: The study was performed on 100 endoscopic biopsies of gastric adenocarcinoma for estrogen receptor expression using an immunohistochemical method, and their relationship with the clinicopathologic findings of the patients, such as age, gender, tumor site, size, grade, depth of tumor invasion (T), and lymphatic status (N), were analyzed using independent sample t-test and Pearson Chi-square test. A P < 0.05 was considered significant in all analyses.
Results: Using an immunohistochemical method on endoscopic biopsies of 74 males and 26 females with the mean age of 63 years, estrogen receptor was found to be positive in 41% of patients. No significant difference was found between estrogen receptor expression and other clinicopathologic findings (P = 0.75). There was a significant difference between estrogen receptor (+) and estrogen receptor (−) groups in nodal involvement (P = 0.001). The estrogen receptor (+) patients had more number of lymph nodes involved.
Conclusion: This study showed that lymph node involvement has a significant relationship with estrogen receptor expression. However, no significant relationship was found between estrogen receptor expression and other clinicopathologic findings such as age, gender, tumor site in stomach, tumor size, tumor grade, and T-stage.

Keywords

1.
International Agency for Research on Cancer (IARC). Working Group Reports Volume 8. Lyon, France. 2000.  Back to cited text no. 1
    
2.
Devita. Cancer principles and practices of Oncology. 2008. Section stomach cancer. Philadelphia, PA: Wolters Kluwer/Lippincott Williams and Wilkins. 2008. p. 1043- 79.  Back to cited text no. 2
    
3.
Song ZJ, Gong P, Wu YE. Relationship between the expression of iNOS, VEGF, tumor angiogenesis and gastric cancer. World J Gastroenterol 2002;8:591-5.  Back to cited text no. 3
    
4.
Tao HQ, Zou SC. Effect of preoperative regional artery chemotherapy on proliferation an apoptosis of gastric carcinoma cells. World J Gastroenterol 2002;8:451-4.  Back to cited text no. 4
    
5.
Xiao HB, Cao WX, Yin HR, Lin YZ, Ye SH. Influence of L-methionine-deprived total parenteral nutrition with 5-flurouracil on gastric cancer an host metabolism. World J Gastroenterol 2001;7:698-701.  Back to cited text no. 5
    
6.
Ma ZF, Wang ZY, Zhang JR, Gong P, Chen HL. Carcinogenic potential of duodenal reflux juice from patients with long standing postgastrectomy. World J Gastroenterol 2001;7:376-80.  Back to cited text no. 6
    
7.
Miehlke S, Kirsch C, Dragosics B, Gschwantler M, Oberhuber G, Antos D, et al. Helicobacter pylori an gastric cancer, Current status of the Austrain Czech German gastric prevention trial (PRISMA Study). World J Gastroenterol 2001;7:243-7.  Back to cited text no. 7
    
8.
Wu K, Shan YJ, Zhao Y, Yu JW, Liu BH. Inhibitory effects of RRR-alpha-tocophery 1 succinate on benzopyrene induced for stomach carcinogenesis in female mice: World J Gastroenterol 2001;7:60-5.  Back to cited text no. 8
    
9.
Zhu B. Detection of estrogen receptors (ER) in gastric cancer. Zhonghua Zhong Liu Za Zhi 1992;13:430-2.  Back to cited text no. 9
    
10.
Stepanov IuM, Kushlinski NE. Qualitative and Quantitative characteristics of estrogen receptors in patients with atrophic gastritis and stomach cancer. Ukr Biokhim Zh 1999;71:86-90.  Back to cited text no. 10
    
11.
Harrison JD, Morris DL, Ellis IO, Jones JA, Jackson I. The effect of tamoxifen and estrogen receptor status on survival in gastric carcinoma. Cancer 1989;64:1007-10.  Back to cited text no. 11
    
12.
Matsui M, Kojima O, Kawakami S, Uehara Y, Takahashi T. The prognosis of patients with gastric cancer possessing sex hormone receptors. Surg Today 1992;22:421-5.  Back to cited text no. 12
    
13.
Oshima CT, Wonraht DR, Catarino RM, Mattos D, Forones NM. Estrogen and progesterone receptors in gastric and colorectal cancer. Hepatogastroenterology 1999;46:3155-8.  Back to cited text no. 13
    
14.
Zhao YF, Zhang YG, Tian XX, Juan Du, Jie Zheng. Aberrant methylation of multiple genes in gastric carcinomas. Int J Surg Pathol 2007;15:242-51.  Back to cited text no. 14
    
15.
Zhao XH, Gu SZ, Pan BR. Expression of estrogen receptor and estrogen receptor messenger RNA in gastric carcinoma tissue. World J Gastroenterol 2003;9:665-9.  Back to cited text no. 15
Advanced Biomedical Research
Volume 2015, August
August 2015
Pages 1-4